SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention

The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a high-risk viral agent involved in the recent pandemic stated worldwide by the World Health Organization. The infection is correlated to a severe systemic and respiratory disease in many cases, which is clinically treated with a mu...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Microorganisms
Κύριοι συγγραφείς: Inchingolo, Alessio Danilo, Inchingolo, Angelo Michele, Bordea, Ioana Roxana, Malcangi, Giuseppina, Xhajanka, Edit, Scarano, Antonio, Lorusso, Felice, Farronato, Marco, Tartaglia, Gianluca Martino, Isacco, Ciro Gargiulo, Marinelli, Grazia, D’Oria, Maria Teresa, Hazballa, Denisa, Santacroce, Luigi, Ballini, Andrea, Contaldo, Maria, Inchingolo, Francesco, Dipalma, Gianna
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: MDPI 2021
Θέματα:
Review
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7999785/
https://ncbi.nlm.nih.gov/pubmed/33806624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/microorganisms9030525
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια